Universe Pharmaceuticals (UPC) Liabilities and Shareholders Equity (2020 - 2025)

Universe Pharmaceuticals (UPC) has 6 years of Liabilities and Shareholders Equity data on file, last reported at $69.3 billion in Q3 2025.

• For the quarter ending Q3 2025, Liabilities and Shareholders Equity rose 1.99% year-over-year to $69.3 billion; the trailing twelve-month figure through Sep 2025 stood at $137.3 billion (up 101.64% YoY), and the FY2025 full-year result was $69.3 billion, up 1.99% from the prior year.
• Liabilities and Shareholders Equity advanced to $69.3 billion in Q3 2025, from $68.0 billion in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $69.3 billion in Q3 2025 to a low of $41.7 million in Q3 2023.
• A 5-year average of $17.2 billion and a median of $70.3 million in 2021 frame the typical range for Liabilities and Shareholders Equity.
• Across the five-year window, Liabilities and Shareholders Equity surged 243521825.1% in 2021 and retreated 29.92% in 2023, its largest moves.
• Tracing UPC's Liabilities and Shareholders Equity over 5 years: stood at $70.1 million in 2021, then retreated by 15.12% to $59.5 million in 2022, then dropped by 29.92% to $41.7 million in 2023, then surged by 162762.16% to $68.0 billion in 2024, then advanced by 1.99% to $69.3 billion in 2025.
• Business Quant data shows UPC's Liabilities and Shareholders Equity at $69.3 billion in Q3 2025, $68.0 billion in Q3 2024, and $49.4 million in Q1 2024.